Michael Kiernan to Feasibility Studies
This is a "connection" page, showing publications Michael Kiernan has written about Feasibility Studies.
Connection Strength
0.084
-
Kapur NK, Kiernan MS, Gorgoshvili I, Yousefzai R, Vorovich EE, Tedford RJ, Sauer AJ, Abraham J, Resor CD, Kimmelstiel CD, Benzuly KH, Steinberg DH, Messer J, Burkhoff D, Karas RH. Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study. Circ Heart Fail. 2022 02; 15(2):e008934.
Score: 0.040
-
Borden M, Kiernan MS, Pham DT, DeNofrio D, Sylvia L. Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios. J Heart Lung Transplant. 2015 Jun; 34(6):860-2.
Score: 0.025
-
Kapur NK, Paruchuri V, Korabathina R, Al-Mohammdi R, Mudd JO, Prutkin J, Esposito M, Shah A, Kiernan MS, Sech C, Pham DT, Konstam MA, Denofrio D. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Heart Lung Transplant. 2011 Dec; 30(12):1360-7.
Score: 0.019